Wall Street Analysts Believe Spruce Biosciences (SPRB) Could Rally 181.21%: Here's is How to Trade

Average Wall Street price targets imply a 181.2% upside for Spruce Biosciences (SPRB). The article notes a positive trend in earnings estimate revisions that could help translate into stock upside, but cautions that price-target averages are of questionable effectiveness. Expect any reaction to be analyst-driven and concentrated at the individual-stock level rather than market-wide.

Analysis

Average Wall Street price targets imply a 181.2% upside for Spruce Biosciences (SPRB). The article notes a positive trend in earnings estimate revisions that could help translate into stock upside, but cautions that price-target averages are of questionable effectiveness. Expect any reaction to be analyst-driven and concentrated at the individual-stock level rather than market-wide.